Home Consent Form Library Clinical ResearchGenetic Research & DNA Banking

Clinical Research Template Tool

Free Genetic Research & DNA Banking Consent Form Template

Operational & Compliance DisclaimerDisclaimer: This template is a sample for operational and administrative purposes only. ConsentCollect is a software platform, not a law firm or a healthcare provider. Consult with qualified legal counsel and medical directors to ensure compliance with local regulations before deploying any clinical consent form.

Professional medical consent form template for Genetic Research & DNA Banking

Informed Consent for Genetic Research, Genomic Sequencing, and Biospecimen Banking

Patient Informed Consent Documentation

Study, Site, and Participant Information

Research Institution / Biobank Sponsor

Principal Investigator

Full Study Protocol Title

IRB Protocol Number

Reviewing IRB / Ethics Committee

ClinicalTrials.gov Identifier (NCT Number)

Participant Full Legal Name

Participant Date of Birth

Voluntary Nature of Participation

Your participation in this genetic research study and the donation of your biological specimens is entirely voluntary. You may choose not to participate. If you agree to participate, you may withdraw your consent at any time without penalty or loss of any medical benefits to which you are otherwise entitled. Your decision will not affect your current or future medical care at this institution. Withdrawing from the study does not recall or delete data or specimens that have already been de-identified, distributed, or analyzed in scientific publications.

Purpose and Scientific Background

You are being invited to participate in a genomic research registry and biobank. Genetic research aims to understand how changes in human DNA (the hereditary code inside cells) affect health and disease. By analyzing genetic material (DNA and RNA) from thousands of individuals, researchers study genetic variations that correlate with specific cardiovascular, oncological, neurological, or metabolic disorders. This study will perform advanced genomic sequencing (such as whole-exome or whole-genome sequencing) to map your genetic profile and correlate it with de-identified clinical history.

Biospecimen Collection and Processing Procedures

Specimen Acquisition: The study team will collect a biological sample from you. This will consist of a standard blood draw (approximately 10 mL to 20 mL of whole blood from a vein in your arm), a saliva sample, or a buccal swab (swabbing the inside of your cheek), depending on the protocol requirements.

DNA and RNA Isolation: Specialized laboratory scientists will extract and isolate genetic material (DNA and RNA) from your biological specimen.

Genomic Analysis: Extracted genetic material will be analyzed using next-generation sequencing technologies. This includes sequencing specific target genes, all protein-coding genes (whole-exome sequencing), or your entire genomic sequence (whole-genome sequencing).

Biobanking: Leftover specimens, genomic sequence files, and related clinical datasets will be stored in secure, temperature-controlled repositories (biobanks) for future, unspecified biomedical research.

Federal Genetic Privacy Protections (GINA)

A federal law called the Genetic Information Nondiscrimination Act (GINA) provides legal protections against genetic discrimination. GINA makes it illegal for health insurance companies, group health plans, and employers with 15 or more employees to write policies or make employment decisions based on your genetic information (such as predisposition to a disease or genomic sequencing results). However, GINA does not apply to life insurance, disability insurance, or long-term care insurance providers, who may request genetic information before issuing policies. The research team will maintain strict electronic separation between your clinical records and genetic data to mitigate this risk.

Mandatory Commercialization and IP Disclosure

Your biological specimens, cell lines, and de-identified genomic data may contribute to the development of new diagnostic tests, diagnostic algorithms, or medical therapies that hold commercial value. Under federal Common Rule guidelines (45 CFR 46.116(c)(9)), you are informed that these materials may be used for commercial profit by the sponsor, research institution, or external biopharma partners. You will not receive any financial compensation, royalties, or proprietary rights from any commercial discoveries or profits derived from your specimens.

Foreseeable Risks and Privacy Disclosures

Physical Risks: For blood draws, risks include transient local pain, bruising, lightheadedness, bleeding, hematoma, or rarely, a local skin infection at the needle insertion site.

Privacy and Re-identification Risks: Your genetic sequence is unique to you. Despite advanced de-identification protocols (such as stripping direct identifiers and using random alphanumeric codes), there is a small risk that public genomic repositories could be cross-referenced with commercial genealogy databases, leading to re-identification of you or your biological relatives. The repository uses secure firewalls and encryption to prevent such breaches.

Psychological Distress: Learning about genetic predispositions to untreatable or late-onset medical conditions (such as Huntington's disease or hereditary dementias) can cause significant anxiety, psychological distress, or family strain.

Return of Incidental and Actionable Findings

During genomic sequencing, researchers may identify 'incidental findings.' These are genetic variants unrelated to the primary study purpose but associated with other serious medical conditions. In accordance with the American College of Medical Genetics and Genomics (ACMG) guidelines, the study team monitors for highly actionable genetic variants (such as BRCA1/BRCA2 mutations for breast cancer risk or Lynch syndrome mutations). If an actionable variant is identified, the team will offer to disclose the results and provide access to a professional genetic counselor. You have the right to opt-in or opt-out of receiving these incidental findings in the options section below.

Reasonable Alternatives to Participation

Choose not to participate in this genetic research study or biobank. Refusing participation will not affect your standard clinical care, access to treatments, or relationship with your healthcare providers.

Obtain clinical genetic testing and counseling outside of this research study through standard clinical channels if recommended by your physician.

Data Sharing and Federal Repositories

To maximize the scientific value of this research, your de-identified genomic sequencing files and health information will be shared with national scientific databases, such as the National Institutes of Health (NIH) Database of Genotypes and Phenotypes (dbGaP). Access to dbGaP is restricted to approved scientific researchers who sign data-use agreements. Your name and direct identifiers will never be shared with these public repositories.

Specimen Withdrawal and Destruction Rules

You may change your mind and request the withdrawal of your specimens from the biobank at any time by contacting the Principal Investigator in writing. Upon receiving your written request, the biobank will locate and destroy any remaining physical biospecimens. However, any samples that have already been fully de-identified, analyzed, shared with federal databases, or used in scientific publications cannot be retrieved, recalled, or destroyed.

Genomic Research Opt-In Elections

[ ] I agree to the indefinite storage of my biological samples and genomic data in the biobank for future secondary research related to any medical condition.

[ ] I do NOT agree to biobanking for future secondary research. My samples must be destroyed upon completion of the primary study.

[ ] I agree to have the research team contact me in the future to return clinically actionable incidental genetic findings.

[ ] I do NOT wish to receive any incidental genetic findings from this study.

Participant Acknowledgment and Authorization

I confirm that I have read this informed consent form. The study team has answered all my questions. I voluntarily agree to participate in this genetic study, donate my biological specimens, and authorize the research use of my genomic data as described.

Signatures and Verification

Participant / LAR Signature

Relationship (if LAR)

Investigator Signature

Witness Signature (if required by IRB)

Date and Time of Consent

Document ID: CC-GENETIC-RESEARCH-CONSENT-FORM

Need to print or customize this template?

Download a clean PDF copy or customize it in our Free Consent Builder. No account required.

Looking for a complete clinical workflow?

Standard PDF consent forms still leave your practice exposed to malpractice disputes. If you want verified patient comprehension quizzes, automated signing order tracking, biometric signature seals, and direct Epic/Cerner EHR FHIR R4 integration, then upgrade to our full ConsentCollect App.

Free Document Schema Specifications

Template Classification:Genetic Research & DNA Banking Layout

Target File Format:Printable PDF / HTML Structure

Customization Capability:Fully Editable Text & Checklist Fields

Licensing & Rights:Free Personal & Practice-Wide Use

How to Use the Digital Genetic Research & DNA Banking Consent Template

The Genetic Research & DNA Banking document layout available on this page is a structured administrative schema designed for clinical research practice managers, compliance coordinators, and healthcare operations teams. Comprehensive, IRB-compliant informed consent form for genetic studies, exome/whole-genome sequencing, biobanking, GINA legal disclosures, and commercialization profit declarations.

Using the ConsentCollect Free Builder, administrative staff can import this genetic research & dna banking schema and configure every field to match their specific facility requirements. The builder supports drag-and-drop field reordering, custom label editing, signature block layout control, and client-side PDF generation, with no coding knowledge required and no account needed.

Once the genetic research & dna banking layout is finalized, it can be printed as a high-resolution paper document, embedded into a digital patient intake kiosk, or exported as a structured JSON payload for integration into an existing EHR or practice management system. Organizations running the full ConsentCollect App subscription gain access to verified comprehension tracking, automated signing sequence management, biometric signature seals, and FHIR R4 interoperability with Epic and Cerner platforms.

❓ Frequently Asked Questions

How do I import and configure this Genetic Research & DNA Banking document layout in the Free Builder?

Click the "Customize in Free Builder" button on this page. The form schema opens directly in the client-side ConsentCollect Free Builder canvas with all fields, sections, and signature blocks pre-loaded. You can then drag and drop additional fields, relabel any section header, swap placeholder text for your facility name and provider credentials, and rearrange the field order to match your clinic workflow, all without creating an account.

What document structure and field types does this Genetic Research & DNA Banking layout include?

This layout contains 14 structured sections covering patient identification fields, administrative intake data, and signature capture blocks. Practice managers and compliance officers can override any field label or placeholder value inside the builder to match their own intake schema.

Can I use this Genetic Research & DNA Banking template for my Clinical Research practice without a paid subscription?

Yes. The Free Advanced Form Builder is entirely public with no account required. You can open this genetic research & dna banking layout, edit all fields, and export a print-ready PDF or copy the underlying JSON schema at no cost. A paid ConsentCollect App subscription unlocks additional workflow features such as encrypted transmission, timestamped audit logs, multi-party signing order, and direct FHIR R4 EHR integrations.

Does this page provide clinical, legal, or medical advice about genetic research & dna banking procedures?

No. This page is an administrative document schema tool hosted by ConsentCollect, a B2B compliance software platform. The form layout is provided for operational and administrative configuration purposes only. ConsentCollect is not a law firm, healthcare provider, or clinical advisory service. Before deploying any consent document to patients, the finished form must be reviewed by your organization's qualified legal counsel and a licensed medical director to confirm compliance with applicable regulations in your jurisdiction.

How do I export, print, or integrate this Genetic Research & DNA Banking form schema into my EHR system?

After editing in the Free Builder, use the Export button to download a high-resolution PDF suitable for physical signature collection. Alternatively, copy the JSON schema payload for use in your own patient intake database or web application. Subscribers to the full ConsentCollect App can push finalized templates directly into Epic or Cerner workflows via a certified FHIR R4 integration layer without any manual re-entry.

Consent Form Moat